Search Results
Results found for "Kenakin"
Posts (113)
- New Tools, Smart Signals, and The Kenakin Brief
Terry Kenakin is launching a new learning space with video courses, AMAs, and practical insights . Get a sneak peek and sign up for The Kenakin Brief—his free weekly newslette r. Terry Kenakin. You can already explore the platform and subscribe to The Kenakin Brief—our new newsletter packed with
- Unlock the Hidden Complexity Behind GPCRs—From Terry Kenakin’s Vault
Terry Kenakin invites us to challenge outdated assumptions and step into a new era of drug discovery.
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
Terry Kenakin , continues to grow. Kenakin. We’re fortunate to partner with Dr. Terry Kenakin , a pioneer who helped shape modern pharmacology and deepen our understanding of GPCR function
Other Pages (17)
- Dr. Terry Kenakin | Dr. GPCR Ecosystem
Terry Kenakin About Dr. Terry Kenakin After obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with Kenakin joined Glaxo Inc in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome Terry Kenakin on the web LinkedIn UNC Department of Pharmacology Amazon ResearchGate Pubmed . Dr.
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Filter by Category Filter by Level Filter by Instructor <p class="font_8">Watch Now</p> Terry Kenakin Action Coming Soon Terry Kenakin The Allosteric Advantage <p class="font_8">Watch Now</p> Sam Hoare Kenakin. I wish Dr. Kenakin is a leading expert in the field. Kenakin is a masterful teacher and communicator.
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
Terry Kenakin < Back Workshop Summary Join Dr. Terry Kenakin , a leading expert in pharmacology, as he unpacks the fascinating world of signaling bias Kenakin will explain that bias is not an exception but a fundamental principle of pharmacology, occurring Kenakin challenges the traditional approach and encourages leveraging bias for better therapeutic outcomes Terry Kenakin’s workshop offers a fresh perspective on drug discovery .





